Cameron CE marks subcutaneous implantable defibrillator
This article was originally published in Clinica
Executive Summary
Cameron Health has CE marked its subcutaneous implantable defibrillator (S-ICD) device, a minimally-invasive system for use in patients at risk of sudden cardiac arrest. The system is entirely subcutaneous, with no leads in or on the heart, and imaging is not required to aid its placement, San Clemente, California-based Cameron claims. Surgical placement and presence of ICD leads within patients' hearts are associated with a significant proportion of the complications seen with the devices. Market launch in selected countries is due to begin this summer.